ViceSpotting

A revolutionary blood-testing technology. A company valued at $9 billion. A founder celebrated as one of Silicon Valley's greatest innovators.

And a promise that couldn't survive scrutiny.

Elizabeth Holmes built Theranos around an extraordinary proposition: hundreds of medical tests from just a few drops of blood. Major investors committed millions, Walgreens became a commercial partner, and the world embraced the story of a healthcare revolution.

But behind the publicity, the company's technology and financial reality told a very different story.

In the inaugural episode of ViceSpotting, we reconstruct the rise and collapse of Theranos: the misleading demonstrations, questionable revenue projections, claims of technological validation, investigative reporting, regulatory scrutiny, and criminal convictions that followed.

Beyond the familiar story of Elizabeth Holmes, we investigate a more consequential question: How does an ambitious technological promise become a fraudulent representation of reality?

An investigation into entrepreneurial deception, investor credibility, the limits of due diligence, and the dangerous distance between what a company promises and what it can actually deliver.

ViceSpotting — Secrets Have Structure.